Dechra Pharmaceuticals plc
TypePublic
LSE: DPH
FTSE 100 component
IndustryPharmaceuticals
Founded1997
HeadquartersNorthwich, England, UK
Key people
Alison Platt, (Chairman)
Ian Page, (CEO)
RevenueIncrease £681.8 million (2022)[1]
Increase £174.3 million (2022)[1]
Increase £58.2 million (2022)[1]
Number of employees
2,036 (2022)[1]
Websitewww.dechra.com

Dechra Pharmaceuticals plc is a business involved in the development and marketing of veterinary products based in Northwich, England. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

History

The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists.[2] It was first listed on the London Stock Exchange in 2000.[2] In 2007 it bought VetXX, a Danish veterinary products business, for £62 million.[3] In 2010 it purchased Florida-based DermaPet for US$64 million[4] and Sussex-based Genitrix for £5 million.[5]

It sold its veterinary services business to US-firm, Patterson Companies, for £87.5m in July 2013 in order to focus on its higher margin manufacturing business.[6]

In June 2023, the private equity organisation, EQT Partners, made an agreed takeover offer for the company which valued the company at £4.5 billion.[7]

Operations

The company sells various pharmaceuticals for common pets and farm animals – mainly for dogs, cats, equine and food producing animals. Their notable products include Vetoryl, a medicine for Cushing's disease in dogs, and Felimazole, medicine for hyperthyroidism in cats. The company is organised into two regional divisions: European Pharmaceuticals and U.S. Pharmaceuticals.[8]

See also

References

  1. 1 2 3 4 "Annual Report 2022" (PDF). Dechra Pharmaceuticals. Retrieved 16 February 2023.
  2. 1 2 "Montague Private Equity announces sale of VetXX".
  3. ↑ "Dechra Pharma to buy VetXX for 61.7 mln stg". Reuters. 12 December 2007. Retrieved 28 March 2015.
  4. ↑ "Dechra Pharma buys DermaPet for US$64 mln". Proactive Investors. 22 October 2010. Retrieved 1 March 2020.
  5. ↑ "Dechra acquires Sussex-based Genitrix in a £5.4m deal". Business Live. 1 December 2010. Retrieved 1 March 2020.
  6. ↑ "Dechra sells up". Investors Chronicle. 11 July 2013. Retrieved 16 March 2014.
  7. ↑ "Dechra Pharmaceuticals agrees £4.5bn takeover deal with Swedish private equity firm". Business Live. 2 June 2023. Retrieved 10 July 2023.
  8. ↑ "Dechra Pharmaceuticals PLC". dechraplc.com. Retrieved 28 March 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.